14 analysts have expressed a variety of opinions on 3M MMM over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 2 | 8 | 4 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 2 | 3 | 2 | 0 |
2M Ago | 0 | 0 | 1 | 1 | 0 |
3M Ago | 0 | 0 | 3 | 1 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $100.29, a high estimate of $126.00, and a low estimate of $78.00. Highlighting a 5.27% decrease, the current average has fallen from the previous average price target of $105.87.
Investigating Analyst Ratings: An Elaborate Study
The standing of 3M among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Stephen Tusa | JP Morgan | Lowers | Neutral | $110.00 | $118.00 |
Andrew Kaplowitz | Citigroup | Raises | Neutral | $98.00 | $95.31 |
Deane Dray | RBC Capital | Lowers | Underperform | $78.00 | $84.00 |
Julian Mitchell | Barclays | Lowers | Overweight | $107.00 | $126.00 |
Andrew Obin | B of A Securities | Lowers | Neutral | $100.00 | $110.00 |
Brett Linzey | Mizuho | Maintains | Neutral | $105.00 | $105.00 |
Deane Dray | RBC Capital | Maintains | Underperform | $84.00 | - |
Julian Mitchell | Barclays | Raises | Overweight | $126.00 | $111.00 |
Julian Mitchell | Barclays | Raises | Equal-Weight | $111.00 | $110.00 |
Deane Dray | RBC Capital | Lowers | Underperform | $84.00 | $85.00 |
Deane Dray | RBC Capital | Raises | Underperform | $87.00 | $83.00 |
Brett Linzey | Mizuho | Lowers | Neutral | $105.00 | $120.00 |
Andrew Kaplowitz | Citigroup | Lowers | Neutral | $104.00 | $117.00 |
Joe O'Dea | Wells Fargo | Lowers | Equal-Weight | $105.00 | $112.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to 3M. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of 3M compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for 3M's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of 3M's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on 3M analyst ratings.
Discovering 3M: A Closer Look
3M is a multinational conglomerate that has operated since 1902, when it was known as Minnesota Mining and Manufacturing. The company is well known for its research and development laboratory and it leverages its science and technology across multiple product categories. As of the second quarter of 2024, 3M is organized across three business segments: safety and industrial, transportation and electronics, and consumer. Nearly 50% of the company's revenue comes from outside the Americas, with the safety and industrial segment constituting a plurality of net sales. Many of the company's tens of thousands of products touch and concern a variety of consumers and end markets.
Key Indicators: 3M's Financial Health
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: 3M's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2023, the company experienced a revenue decline of approximately -0.82%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: 3M's net margin excels beyond industry benchmarks, reaching 11.79%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): 3M's ROE stands out, surpassing industry averages. With an impressive ROE of 19.94%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): 3M's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.89% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: 3M's debt-to-equity ratio is below the industry average. With a ratio of 3.51, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyst Ratings: What Are They?
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.